Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michail E Kalaitzakis

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Acta Neuropathologica|October 13, 2009
The morbid anatomy of dementia in Parkinson's diseaseMichail E Kalaitzakis, Ronald K B Pearce
Journal of Neuropathology and Experimental Neurology|January 26, 2008
Striatal beta-amyloid deposition in Parkinson disease with dementiaMichail E Kalaitzakis, Manuel B Graeber, Stephen M Gentleman, et al.
SAGE Open Medicine|January 16, 2016
A prospective non-interventional study for evaluation of quality of life in patients with Alzheimer's disease treated with rivastigmine transdermal patchVassileios Vagenas, Georgios S Vlachos, Nikoleta Vlachou, et al.
Acta Neuropathologica Communications|February 18, 2014
Phenotypic profile of alternative activation marker CD163 is different in Alzheimer's and Parkinson's diseasePeixuan Pey, Ronald K B Pearce, Michail E Kalaitzakis, et al.
Acta Neuropathologica|November 8, 2007
Neuronal pentraxin II is highly upregulated in Parkinson's disease and a novel component of Lewy bodiesLinda B Moran, Lorraine Hickey, Gregory J Michael, et al.
Acta Neuropathologica Communications|April 27, 2019
Hippocampal CA2 Lewy pathology is associated with cholinergic degeneration in Parkinson's disease with cognitive declineAlan King Lun Liu, Tsz Wing Chau, Ernest Junwei Lim, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Acta Neuropathologica|October 13, 2009
The morbid anatomy of dementia in Parkinson's diseaseMichail E Kalaitzakis, Ronald K B Pearce
Journal of Neuropathology and Experimental Neurology|January 26, 2008
Striatal beta-amyloid deposition in Parkinson disease with dementiaMichail E Kalaitzakis, Manuel B Graeber, Stephen M Gentleman, et al.
SAGE Open Medicine|January 16, 2016
A prospective non-interventional study for evaluation of quality of life in patients with Alzheimer's disease treated with rivastigmine transdermal patchVassileios Vagenas, Georgios S Vlachos, Nikoleta Vlachou, et al.
Acta Neuropathologica Communications|February 18, 2014
Phenotypic profile of alternative activation marker CD163 is different in Alzheimer's and Parkinson's diseasePeixuan Pey, Ronald K B Pearce, Michail E Kalaitzakis, et al.
Acta Neuropathologica|November 8, 2007
Neuronal pentraxin II is highly upregulated in Parkinson's disease and a novel component of Lewy bodiesLinda B Moran, Lorraine Hickey, Gregory J Michael, et al.
Acta Neuropathologica Communications|April 27, 2019
Hippocampal CA2 Lewy pathology is associated with cholinergic degeneration in Parkinson's disease with cognitive declineAlan King Lun Liu, Tsz Wing Chau, Ernest Junwei Lim, et al.
Pageof 1